Emerging Bioactive Agent Delivery-Based Regenerative Therapies for Lower Genitourinary Tissues

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Urology

Background:

• Lower genitourinary (GU) tissue injuries can lead to infertility and organ dysfunction, impacting overall human health.
• Bioactive agent-based regenerative therapy is a promising treatment, but challenges remain in achieving optimal spatiotemporal delivery for sustained disease management.

Purpose of the Study:

• To review advancements in bioactive agent delivery systems for lower GU regenerative therapy.
• To explore innovations in biomedical components, fabrication methods, and loading strategies for enhanced delivery system performance.
• To discuss the application and potential of these advanced delivery systems in treating lower GU injuries.

Main Methods:

• Review of current literature on bioactive agent delivery systems for regenerative medicine.
• Analysis of biomedical innovations, fabrication techniques (e.g., 3D printing), and loading strategies.
• Examination of recent applications and outcomes in treating lower GU injuries in preclinical models and patients.

Main Results:

• Advanced strategies enable the development of more functional, precise, and "smart" bioactive agent delivery systems.
• These improved delivery systems have demonstrated positive effects in treating lower GU injuries in both animal models and human patients.
• Progress in biomaterials, therapeutic agents, and fabrication technologies is continuously enhancing regenerative therapy potential.

Conclusions:

• Delivery-based regenerative therapies hold significant promise for treating lower GU disorders and dysfunctions.
• Continued evolution of biomaterials, therapeutic agents, and advanced manufacturing techniques will drive future therapeutic advancements.
• Optimized bioactive agent delivery is crucial for effective and sustained management of lower GU injuries.